Drug
Raav Sflt 1
Raav Sflt 1: highest development phase Phase 1/2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| rAAV.sFlt-1 NCT01494805 | Phase 1/2 | Macular Degeneration |
Latest
No recent events.
Follow Raav Sflt 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.